Topic
Mutation-directed cancer treatment replacing broad cytotoxic chemotherapy.
A Nature paper from the University of Zurich and the CNIO reports that cohesin is pulled to sites where DNA replication is disrupted, holds the new copy in a protective arrangement, and keeps the error-prone restart factor Primpol switched off.
Reality
Hana Asset Management's medical AI fund led every ETF listed in South Korea last week, helped by a Morgan Stanley estimate that Medicare coverage could add $330m to $400m of annual revenue at its largest holding.
Reality
Mount Sinai and CPTAC collaborators measured DNA, RNA, proteins and protein modifications in tumors from patients aged 83 days to 40 years. Molecular profiles and survival split adolescents and young adults into two groups.
Reality
The evidence behind the expansion is two partial responses and six stable diseases among 28 heavily pretreated patients, with both detailed responders carrying a PPP2R1A mutation. The point of adding sites is to find out whether that pattern holds.
Reality
A Nature Communications model from Weill Cornell argues that a target protein's turnover rate can matter as much as how tightly a degrader binds it, which would reorder where degrader programs spend their optimisation money.
Reality